Evaluation Of Cardiovascular Health Outcomes Among Survivors 2
ConditionHealth Behavior
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age26+
SponsorSt. Jude Children's Research Hospital
About this trial
Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.
Eligibility criteria
Qualifiers
Childhood Cancer Survivor Study (CCSS) Participants
Age ≥26 years
Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines
No history of cardiomyopathy
Disqualifiers
None
Trial design
Treatments tested in this trial
- Survivorship Care Plan + Educational Materials (delivered via CIAS platform)
- Healthy Hearts eHealth Program
Treatment groups
350 Participants
are divided into 2 treatment groupsSponsors and collaborators
St. Jude Children's Research Hospital
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov